Go to Bond University home page

Publications 2017

Research Articles

  1. Jansen J, McKinn S, Bonner C, Irwig L, Doust J, Glasziou P, et al. (2017) General Practitioners’ Decision Making about Primary Prevention of Cardiovascular Disease in Older Adults: A Qualitative Study. PLoS ONE 12(1): e0170228
  2. Brownlee, S., Chalkidou, K., Doust, J., Elshaug, A.G., Glasziou, P., Heath, I., Nagpal, S., Saini, V., Srivastava, D., Chalmers, K., Korenstein, D. (2017) Evidence for overuse of medical services around the world. Lancet, 390 (10090): 156-168
  3. Glasziou, P., Straus, S., Brownlee, S., Trevena, L., Dans, L., Guyatt, G., Elshaug, A.G., Janett, R., Saini, V. (2017) Evidence for underuse of effective medical services around the world. Lancet, 390(10090): 169-177
  4. Hoffmann, T.C., Del Mar, C. (2017). Clinicians’ Expectations of the Benefits and Harms of Treatments, Screening, and Tests: A Systematic Review. JAMA Internal Medicine, 177(3):407-419.
  5. Moynihan, R., Sims, R., Hersch, J., Thomas, R., Glasziou, P.P., McCaffery, K. (2017). Communicating about overdiagnosis: Learning from community focus groups on osteoporosis. PLoS One, 12(2):e0170142
  6. Cleo, G., Isenring, E., Thomas, R., Glasziou, P. (2017) Could habits hold the key to weight loss maintenance? A narrative review. J Hum Nutr Diet, 30(5): 655-664.
  7. Odgers-Jewell, K., Ball, L.E., Kelly, J.T., Isenring, E.A., Reidlinger, D.P., Thomas, R. (2017), Effectiveness of group-based self-management education for individuals with Type 2 diabetes: a systematic review with meta-analyses and meta-regression. Diabet. Med. 34(8): 1027-1039
  8. Bell, K.J., Mehta, Y., Turner, R.M., Morton, R.L., Dieng, M., Saw, R., Guitera, P., McCaffery, K., Low, D., Low, C., Jenkins, M., 2017. Fear of new or recurrent melanoma after treatment for localised melanoma. Psycho-oncology, 26(11): 1784-1791
  9. Coxeter, P.D., Del Mar, C., Hoffmann, T.C. (2017). Parents’ Expectations and Experiences of Antibiotics for Acute Respiratory Infections in Primary Care. The Annals of Family Medicine, 15(2):149-154.
  10. Degeling, C., Rychetnik, L., Street, J., Thomas, R., Carter, S.M. (2017) Influencing health policy through public deliberation: Lessons learned from two decades of Citizens’/community juries. Social Science & Medicine, 179, pp.166-171.
  11. Moro, C., Bass, J., Scott, A.M., Canetti, E.F.D. (2017). Enhancing capillary blood collection: The influence of nicotinic acid and nonivamide. J Clin Lab Anal. 31(6):e22142.
  12. Nickel, B., Brito, J.P., Barratt, A., Jordan, S., Moynihan, R., McCaffery, K. (2017) Clinicians’ Views on Management and Terminology for Papillary Thyroid Microcarcinoma: A Qualitative Study. Thyroid, 27(5):661-671. 
  13. Ranakusuma, R.W., Pitoyo, Y., Safitri, E.D., Widyahening, I.S., Beller, E.M., Glasziou, P.P., Bashiruddin, J. (2017) Therapeutic ultrasound for chronic rhinosinusitis (Protocol). Cochrane Database Syst Rev, Issue 3. Art. No.: CD011046.
  14. Sargent, L., McCullough, A., Del Mar, C., Lowe, J. (2017). Using theory to explore facilitators and barriers to delayed prescribing in Australia: a qualitative study using the Theoretical Domains Framework and the Behaviour Change Wheel. BMC Family Practice, 18(1), p.20.
  15. Coxeter, P., Del Mar, C.,  Hoffmann, T. (2017). Preparing parents to make an informed choice about antibiotic use for common acute respiratory infections in children: a randomised trial of brief decisions aids in a hypothetical scenario. The Patient: Patient Centered Outcomes Research, 10(4), 463-474
  16. Cusack, L., Desha, L., Del Mar, C., Hoffmann, T. (2017). A qualitative study exploring high school students’ understanding of, and attitudes towards, health information and claims. Health Expectations. DOI: 10.1111/hex.12562 [online early]
  17. Abell, B., Glaszion, P., Hoffmann, T. (2017). The contribution of individual exercise training components to clinical outcomes in randomised controlled trials of cardiac rehabilitation: a systematic review and meta-regression. Sports Medicine Open. 3:19.
  18. Ludemann, A., Power, E., Hoffmann, T. (2017). Investigating the adequacy of intervention descriptions in recent speech-language pathology literature – is evidence from randomised trials useable? American Journal of Speech-Language Pathology, 26(2), 443-455.
  19. Furuya-Kanamori, L., Doi, S.A., Paterson, D.L., Helms, S.K., Yakob, L., McKenzie, S.J., Garborg, K., Emanuelsson, F., Stollman, N., Kronman, M.P., Clark, J., et al. (2017). Upper versus lower gastrointestinal delivery for transplantation of fecal microbiota in recurrent or refractory Clostridium difficile infection: a collaborative analysis of individual patient data from 14 studies. Journal of clinical gastroenterology, 51(2), pp.145-150.
  20. Scott, A.M., Hofmann, B., GutiĂŠrrez-Ibarluzea, I., Bakke Lysdahl, K., Sandman, L., Bombard, Y. (2017). Q-SEA – a tool for quality assessment of ethics analyses conducted as part of health technology assessments. GMS Health Technology Assessment, 13, [Doc02]. DOI: 10.3205/hta000128
  21. Alloo, J., Vallath, S., Del Mar, C., Carter, M., Thorning, S., Clark, J. (2017). Determining the gaps between Cochrane reviews and trials of effectiveness of interventions for acute respiratory infections: an audit. Systematic Reviews, 6(1), p.82.
  22. Albarqouni, L.N., LĂłpez-LĂłpez, J.A., Higgins, J.P.T. (2017). Indirect evidence of reporting biases was found in a survey of medical research studies. Journal of Clinical Epidemiology, 83, 57-64.
  23. Doust, J., Vandvik, P.O., Qaseem, A., Mustafa, R.A., Horvath, A.R., Frances, A., Al-Ansary, L., Bossuyt, P., Ward, R.L., Kopp, I., Gollogly, L., Schunemann, H., Glasziou, P. (2017). Guidance for Modifying the Definition of Diseases: A Checklist. JAMA Internal Medicine, 177(7): 1020-1025
  24. Albarqouni, L., Doust, J., Glasziou, P. (2017). Patient preferences for cardiovascular preventive medication: a systematic review. Heart, pp.heartjnl-2017.
  25. Odgers-Jewell, K., Isenring, E.A., Thomas, R., Reidlinger, D.P. (2017). Group participants’ experiences of a patient-directed group-based education program for the management of type 2 diabetes mellitus. PLoS one, 12(5), p.e0177688.
  26. Sharples, J.M., Oxman, A.D., Mahtani, K.R., Chalmers, I., Oliver, S., Collins, K., Austvoll-Dahlgren, A., Hoffmann, T. (2017). Critical thinking in healthcare and education. BMJ, 357, p.j2234.
  27. Trevena, L., Shepherd, H.L., Bonner, C., Jansen, J., Cust, A.E., Leask, J., Shadbolt, N., Del Mar, C., McCaffery, K., Hoffmann, T. (2017). Shared Decision Making in Australia in 2017. Partizipative Entscheidungsfindung in Australien im Jahr 2017. Zeitschrift fĂźr Evidenz, Fortbildung und Qualität im Gesundheitswesen, 123-124; 17-20
  28. Odgers-Jewell, K., Isenring, E.A., Thomas, R., Reidlinger, D.P. (2017). Group-based education for patients with type 2 diabetes: a survey of Australian dietitians. Australian Journal of Primary Health, 23(4): 364-372
  29. Bell, K.J., Hayen, A., Glasziou, P., Mitchell, A.S., Farris, M., Wright, J., Duerr, H.P., Mitchell, P., Irwig, L. (2017). Early CRT monitoring using time-domain optical coherence tomography does not add to visual acuity for predicting visual loss in patients with central retinal vein occlusion treated with Intravitreal Ranibizumab: A secondary analysis of trial data. Retina, 37(3), pp.509-514.
  30. Medew, J., Moynihan, R. (2017). Improving coverage of medical research in a changing media environment. CMAJ, 189(15), p.E551-E552.
  31. Jones, M., Del Mar, C., Doshi, P. (2017). Findings of an observational study of neuraminidase inhibitors highly sensitive to decision to exclude 1652 treated patients. Clinical Infectious Diseases, p.cix425.
  32. Abell, B., Glasziou, P., Hoffmann, T. (2017). Exploration of the methodological quality and clinical usefulness of a cross-sectional sample of published guidance about exercise training and physical activity for the secondary prevention of coronary heart disease. BMC Cardiovascular Disorders, 17(1), p.153.
  33. Wale, J., Scott, A.M., Hofmann, B., Garner, S., Low, E., Sansom, L. (2017). Why patients should be involved in health technology assessment. International Journal of Technology Assessment in Health Care, 33(1):1-4.
  34. Doust, J., Jean Walker, M., Rogers, W.A. (2017). Current Dilemmas in Defining the Boundaries of Disease. Journal of Medicine and Philosophy, 42: 350–366.
  35. Copp, T., McCaffery, K., Azizi, L., Doust, J., Mol, B.W., Jansen, J. (2017). Influence of the disease label ‘polycystic ovary syndrome’ on intention to have an ultrasound and psychosocial outcomes: a randomised online study in young women. Human Reproduction, 32(4):876-884.
  36. Albarqouni, L., Abu-Rmeileh, N.M., Elessi, K., Obeidallah, M., Bjertness, E., Chalmers, I., 2017. The quality of reports of medical and public health research from Palestinian institutions: a systematic review. BMJ open, 7(6), p.e016455.
  37. Fabbri, A., Grundy, Q., Mintzes, B., Swandari, S., Moynihan, R., Walkom, E., Bero, L.A., 2017. A cross-sectional analysis of pharmaceutical industry-funded events for health professionals in Australia. BMJ open, 7(6), p.e016701.
  38. Hoffmann, T., Glasziou, P., Beller, E., Goldacre, B., Chalmers, I., 2017. Focus on sharing individual patient data distracts from other ways of improving trial transparency. BMJ, 357: j2782.
  39. Johnston, A.N., Park, J., Doi, S.A., Sharman, V., Clark, J., Robinson, J., Crilly, J., 2017. Effect of Immediate Administration of Antibiotics in Patients With Sepsis in Tertiary Care: A Systematic Review and Meta-analysis. Clinical Therapeutics, 39(1): 190-202.e6.
  40. Nickel, B., Barratt, A., Copp, T., Moynihan, R., McCaffery, K., 2017. Words do matter: a systematic review on how different terminology for the same condition influences management preferences. BMJ open, 7(7), p.e014129.
  41. Walker, M.F., Hoffmann, T.C., Brady, M.C., Dean, C.M., Eng, J.J., Farrin, A.J., Felix, C., Forster, A., Langhorne, P., Lynch, E.A., Radford, K.A., 2017. Improving the development, monitoring and reporting of stroke rehabilitation research: Consensus-based core recommendations from the Stroke Recovery and Rehabilitation Roundtable. International Journal of Stroke, 12(5), pp.472-479.
  42. Castle, J.C., Chalmers, I., Atkinson, P., Badenoch, D., Oxman, A.D., Austvoll-Dahlgren, A., Nordheim, L., Krause, L.K., Schwartz, L.M., Woloshin, S., Burls, A., Mosconi, P., Hoffmann, T., Cusack, L., Albarqouni, L., Glasziou, P. 2017. Establishing a library of resources to help people understand key concepts in assessing treatment claims—The “Critical thinking and Appraisal Resource Library”(CARL). PLoS One, 12(7), p.e0178666.
  43. Hoffmann, T.C., Oxman, A.D., Ioannidis, J.P., Moher, D., Lasserson, T.J., Tovey, D.I., Stein, K., Sutcliffe, K., Ravaud, P., Altman, D.G., Perera, R., 2017. Enhancing the usability of systematic reviews by improving the consideration and description of interventions. BMJ, 358, p.j2998.
  44. Scott, A.M., Wale, J.L., 2017. Patient advocate perspectives on involvement in HTA: an international snapshot. Research Involvement and Engagement, 3(1), p.2.
  45. Hoffmann, T., Straus, S. E. (2017). Sharing knowledge for health care. JAMA Internal Medicine, 177(9): 1243-1244
  46. Odgers‐Jewell, K., Isenring, E., Thomas, R., Reidlinger, D.P., 2017. Process evaluation of a patient‐centred, patient‐directed, group‐based education program for the management of type 2 diabetes mellitus. Nutrition & Dietetics, 74(3), pp.243-252.
  47. Pathirana, T., Clark, J., Moynihan, R. 2017. Mapping the drivers of overdiagnosis to potential solutions. BMJ, 358:j3879
  48. Copp, T., Jansen, J., Doust, J., Mol, B.W., Dokras, A., McCaffery, K., 2017. Are expanding disease definitions unnecessarily labelling women with polycystic ovary syndrome? BMJ, 358, p.j3694.
  49. Bernhardt, J., Borschmann, K., Boyd, L., Carmichael, S.T., Corbett, D., Cramer, S.C., Hoffmann, T., Kwakkel, G., Savitz, S., Saposnik, G., Walker, M., 2017. Moving rehabilitation research forward: developing consensus statements for rehabilitation and recovery research. Neurorehabilitation and Neural Repair, 31(8), pp.694-698.
  50. Sanders, S.L., Rathbone, J., Bell, K.J., Glasziou, P.P., Doust, J.A., 2017. Systematic review of the effects of care provided with and without diagnostic clinical prediction rules. Diagnostic and Prognostic Research, 1(1), p.13.
  51. McCullough, A.R., Pollack, A.J., Plejdrup Hansen, M., Glasziou, P.P., Looke, D.F., Britt, H.C., Del Mar, C.B., 2017. Antibiotics for acute respiratory infections in general practice: comparison of prescribing rates with guideline recommendations. MJA, 207(2), pp.65-69.
  52. Thomas, R., Abell, B., Webb, H.J., Avdagic, E., Zimmer-Gembeck, M.J., 2017. Parent-Child Interaction Therapy: A Meta-analysis. Pediatrics, 140(3), p.e20170352.
  53. Albarqouni, L., Elessi, K., 2017. Awareness, attitudes, and knowledge of Palestinian doctors about evidence-based medicine: a cross-sectional survey. The Lancet, 390, p.S14.
  54. Spurling, G.K., Del Mar, C.B., Dooley, L., Foxlee, R., Farley, R., 2017. Delayed antibiotic prescriptions for respiratory infections (Review). Cochrane Database of Systematic Reviews 2017, Issue 9. Art. No.: CD004417.
  55. Tonkin‐Crine, S.K., Tan, P.S., van Hecke, O., Wang, K., Roberts, N.W., McCullough, A.,Hansen, M.P., Butler, C.C., Del Mar, C.B., 2017. Clinician-targeted interventions to influence antibiotic prescribing behaviour for acute respiratory infections in primary care: an overview of systematic reviews.  Cochrane Database of  Systematic Reviews 2017, Issue 9. Art. No.:CD012252.
  56. Barvour, V., Bhui, K., Chescheir, N., Clavien, P.A., Diener, M.K., Glasziou P., et al. 2017. CONSORT statement for randomized trials of nonpharmacologic treatments: a 2017 update and a CONSORT extension for nonpharmacologic trial abstracts. Annals of Internal Medicine, 167(1), 40-47.
  57. Glasziou, P. 2017. Der Tatsache ins Auge sehen: Wir Ärzte tun zu viel (Let’s face the problem: We doctors do too much). Zeitschrift fur Allgemeinmedizin, 93(6):245-249
  58. Shea, B.J., Reeves, B.C., Wells, G., Thuku, M., Hamel, C., Moran, J., Moher, D., Tugwell, P., Welch, V., Kristjansson, E., Henry, D.A., 2017. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ, 358, p.j4008.
  59. Harris, M.F., Parker, S.M., Litt, J., van Driel, M., Russell, G., Mazza, D., Jayasinghe, U.W., Smith, J., Del Mar, C., Lane, R. and Denney-Wilson, E., 2017. An Australian general practice based strategy to improve chronic disease prevention, and its impact on patient reported outcomes: evaluation of the preventive evidence into practice cluster randomised controlled trial. BMC Health Services Research, 17(1), p.637.
  60. Cohen, J.F., Korevaar, D.A., Gatsonis, C.A., Glasziou, P.P., Hooft, L., Moher, D., Reitsma, J.B., de Vet, H.C. and Bossuyt, P.M., 2017. STARD for Abstracts: essential items for reporting diagnostic accuracy studies in journal or conference abstracts. BMJ, 358, j3751.
  61. Ho, C.L.B., Sanders, S., Doust, J., Breslin, M., Reid, C.M. and Nelson, M.R., 2017. Legacy Effect of Delayed Blood Pressure-Lowering Pharmacotherapy in Middle-Aged Individuals Stratified by Absolute Cardiovascular Disease Risk: Protocol for a Systematic Review. JMIR research protocols, 6(9): e177.
  62. Thomas, J., Noel-Storr, A., Marshall, I., Wallace, B., McDonald, S., Mavergames, C., Glasziou, P., Shemilt, I., Synnot, A., Turner, T., Elliott, J., 2017. Living systematic reviews: 2. Combining human and machine effort. Journal of Clinical Epidemiology, 91:31-37.
  63. Stehlik, P., Frotjold, A. and Schneider, C.R., 2017. Effect of hospital simulation tutorials on nursing and pharmacy student perception of interprofessional collaboration: Findings from a pilot study. Journal of Interprofessional Care, 32(1): 115-117, 
  64. Del Mar, C., 2017. Guideline: An expert panel strongly recommends against arthroscopic knee surgery for degenerative knee disease. Annals of internal medicine, 167(8), p.JC38.
  65. Del Mar, C., Collignon, P., 2017. How can we prepare better for influenza epidemics? BMJ, 359:j5007.
  66. Del Mar, C.B., Scott, A.M., Glasziou, P.P., Hoffmann, T., van Driel, M.L., Beller, E., Phillips, S.M., Dartnell, J., 2017. Reducing antibiotic prescribing in Australian general practice: time for a national strategy. MJA, 207(9), 401-406
  67. Scanlan, J. N., Lannin, N. A., Hoffmann, T., Stanley, M., McDonald, R. (2017), Impact of adjusting for inter-rater variability in conference abstract ranking and selection processes. Aust Occup Ther J. doi:10.1111/1440-1630.12440
  68. Warner, M., Kelly, J., Reidlinger, D., Hoffmann, T., Campbell, K. (2017). Reporting of telehealth-delivered dietary intervention trials in chronic disease. JMIR, 19(12):e410.
  69. Austvoll-Dahlgren, A., Guttersrud, Ø., Nsangi, A., Semakula, D., Oxman, A., The IHC group*.(2017). Measuring ability to assess claims about treatment effects: a latent trait analysis of items from the ‘Claim Evaluation Tools’ database using Rasch modelling. BMJ Open 7(5): e013185.
  70. Austvoll-Dahlgren, A., Semakula, D., Nsangi, A., Oxman, A., Chalmers, I., Rosenbaum, S., Guttersrud, Ø., The IHC group*. (2017). Measuring ability to assess claims about treatment effects: the development of the “Claim Evaluation Tools”. BMJ Open 7(5): e013184.
  71. Zhang, L., Badve, S.V., Pascoe, E.M., Beller, E., Cass, A., Clark, C., de Zoysa, J., Isbel, N.M., Liu, X., McTaggart, S., Morrish, A.T., 2017. Representativeness of Honeypot Trial Participants to Australasian PD Patients. Peritoneal Dialysis International, 37(5), pp.516-522.
  72. Lum, E.P., Page, K., Nissen, L., Doust, J., Graves, N., 2017. Australian consumer perspectives, attitudes and behaviours on antibiotic use and antibiotic resistance: a qualitative study with implications for public health policy and practice. BMC Public Health, 17(1), p.799.
  73. Rathbone, J., Albarqouni, L., Bakhit, M., Beller, E., Byambasuren, O., Hoffmann, T., Scott, A.M., Glasziou, P., 2017. Expediting citation screening using PICo-based title-only screening for identifying studies in scoping searches and rapid reviews. Systematic Reviews, 6:233
  74. Bonner, C., McKinn, S., Lau, A., Jansen, J., Doust, J., Trevena, L., McCaffery, K., 2017. Heuristics and biases in cardiovascular disease prevention: How can we improve communication about risk, benefits and harms? Patient Education and Counseling, 101(5): 843-853
  75. Ho, C., Breslin, M., Doust, J., Reid, C., Nelson, M., 2017. Effectiveness of blood pressure-lowering drug treatment by levels of absolute risk: post hoc analysis of the Australian National Blood Pressure Study.BMJ open, 8(3): e017723
  76. Fine, B., Schultz, S.E., White, L., Henry, D., 2017. Impact of restricting diagnostic imaging reimbursement for uncomplicated low back pain in Ontario: a population-based interrupted time series analysis. CMAJ open, 5(4), pp.E760-E767.
  77. Walker, J., Lovett, R., Kukutai, T., Jones, C., Henry, D., 2017. Indigenous health data and the path to healing. The Lancet, 390(10107), pp.2022-2023.
  78. Weeks, L., Polisena, J., Scott, A.M., Holtorf, A.P., Staniszewska, S., Facey, K., 2017. Evaluation of patient and public involvement initiatives in health technology assessment: A survey of international agencies. International Journal of Technology Assessment in Health Care, pp.1-9.
  79. Gomes, T., Mastorakos, A., Paterson, J.M., Sketris, I., Caetano, P., Greaves, S., Henry, D. and Canadian Network for Observational Drug Effect Studies Investigators, 2017. Changes in the dispensing of opioid medications in Canada following the introduction of a tamper-deterrent formulation of long-acting oxycodone: a time series analysis. CMAJ open, 5(4), E800-E807.
  80. Thomas, E.T., Del Mar, C., Glasziou, P., Wright, G., Barratt, A., Bell, K.J., 2017. Prevalence of incidental breast cancer and precursor lesions in autopsy studies: a systematic review and meta-analysis. BMC cancer, 17(1), p.808.
  81. Walker, M.F., Hoffmann, T.C., Brady, M.C., Dean, C.M., Eng, J.J., Farrin, A.J., Felix, C., Forster, A., Langhorne, P., Lynch, E.A., Radford, K.A., 2017. Improving the development, monitoring and reporting of stroke rehabilitation research: Consensus-based core recommendations from the Stroke Recovery and Rehabilitation Roundtable. Neurorehabilitation and Neural Repair, 31(10-11), pp.877-884.
  82. Bell, K.J., McCullough, A., Del Mar, C., Glasziou, P., 2017. What’s the uptake? Pragmatic RCTs may be used to estimate uptake, and thereby population impact of interventions, but better reporting of trial recruitment processes is needed. BMC Medical Research Methodology, 17(1):174.
  83. Lucey, M., Clark, J., Glasziou, P., 2017. Public availability of trial protocols. The Lancet, 390(10113), e54-e55.
  84. Ko, H., Hunter, K.E., Scott, A.M., Ayson, M., Willson, M.L., 2017. A systematic review of performance-enhancing pharmacologicals and biotechnologies in the Army. Journal of the Royal Army Medical Corps, 164(3): 197-206
  85. Albarqouni, L., Elessi, K., 2017. Awareness, attitudes and knowledge about evidence-based medicine among doctors in Gaza: A cross-sectional survey. Eastern Mediterranean Health Journal, 23(9), p.626.
  86. Furuya‐Kanamori, L., Wangdi, K., Yakob, L., McKenzie, S. J., Doi, S. A., Clark, J., ... & Clements, A. C. (2017). 25‐hydroxyvitamin D concentrations and clostridium difficile infection: a meta‐analysis. Journal of Parenteral and Enteral Nutrition, 41(5), 890-895.

Books

  1. Hoffmann, T.C., Bennett, S., Del Mar, C.B. (eds) 2017. Evidence-based practice across the health professions. 3rd edn, Elsevier Australia, Chatswood NSW.

Other

  1. Saini, V., Brownlee, S., Elshaug, A.G., Glasziou, P., Heath, I. (2017) Addressing overuse and underuse around the world. The Lancet, 390(10090), 105-107.
  2. Nasser, M., Clarke, M., Chalmers, I., Brurberg, K.G., Nykvist, H., Lund, H., Glasziou, P. (2017) What are funders doing to minimise waste in research? The Lancet, 389(10073), pp.1006-1007.
  3. Traeger, A.C., Moynihan, R., Maher, C.G. (2017). Wise choices: making physiotherapy care more valuable. Journal of Physiotherapy, 63(2): 63-65
  4. Yamato, T., Maher, C., Saragiotto, B., Moseley, A., Hoffmann, T., Elkins, M. and Hasson, S. (2017). The TIDieR checklist will benefit the physiotherapy profession. Physiotherapy Theory and Practice: An International Journal of Physical Therapy, 33(4): 267-268
  5. Scott, A.M., Del Mar, C. (2017). Controlling antibiotic prescribing for lower respiratory tract infections. BMJ, 357: j2398
  6. Del Mar, C., Looke, D.F.M. (2017). Should we abandon “finishing the course” of antimicrobials? BMJ, 358:j4170
  7. Del Mar, C., Collignon, P., 2017. How can we prepare better for influenza epidemics?. BMJ, 359, p.j5007.
  8. Bell, K.J., Hayen, A., Glasziou, P., Irwig, L., Bauer, D.C. (2017). Change in Bone Mineral Density Is an Indicator of Treatment-Related Antifracture Effect. Annals of internal medicine, 166(2):152.
  9. Moynihan, R., Bero, L. (2017) Toward a Healthier Patient Voice: More Independence, Less Industry Funding. JAMA Internal Medicine, 177(3), pp.350-351.
  10. Scott, A., Wale, J., Bertelson, N., Meade, N. (2017). Strengthening international patient advocacy perspectives on patient involvement in HTA within the HTAi Patient and Citizen Involvement Interest Group – Commentary. Research Involvement and Engagement, 3(3).
  11. Sargent, L., McCullough, A., Del Mar, C., Lowe, J. (2017). Delayed prescribing in primary care-Reply. Australian Family Physician, 46(1), 6-8.
  12. Hoffmann, T.C., Del Mar., C. 2017. Discrepant Expectations About Benefits and Harms – Reply. JAMA Internal Medicine, 177(8), 1226-1227
  13. Doust, J., Qaseem, A., Glasziou, P., 2017. Considerations Concerning Disease Redefinition—reply. JAMA internal medicine, 177(12), pp.1873-1873.
By browsing this site you accept that cookies are used to improve and personalise our services to you for a better experience on our website and for social activity. If you continue, we will assume that you agree to our use of cookies statement
I Agree